Literature DB >> 31535931

Twenty-Four-Hour Reocclusion After Successful Mechanical Thrombectomy: Associated Factors and Long-Term Prognosis.

João Pedro Marto1,2, Davide Strambo1, Steven D Hajdu3, Ashraf Eskandari1, Stefania Nannoni1, Gaia Sirimarco1, Bruno Bartolini3, Francesco Puccinelli3, Philippe Maeder1,3, Guillaume Saliou3, Patrik Michel.   

Abstract

Background and Purpose- Early arterial recanalization is a strong determinant of prognosis in acute ischemic stroke. Nevertheless, reocclusion can occur after initial recanalization. We assessed associated factors and long-term prognosis of reocclusion after successful mechanical thrombectomy (MT). Methods- From the prospectively constructed Acute Stroke Registry and Analysis of Lausanne cohort, we included consecutive patients with anterior and posterior circulation strokes treated by successful MT (modified treatment in cerebral infarction 2b-3) and with 24-hour vascular imaging available. Reocclusion at this time-point was defined as new intracranial occlusion within an arterial segment recanalized at the end of MT. Through multivariate logistic regression, we investigated associated factors and 3-months outcome. In a 4:1 matched-cohort, we also assessed the role of residual thrombus or stenosis on post-recanalization angiographic images as potential predictor of reocclusion. Results- Among 473 patients with successful recanalization, 423 (89%) were included. Of these, 28 (6.6%) had 24-hour reocclusion. Preadmission statin therapy (aOR [adjusted odds ratio], 0.27; 95% CI, 0.08-0.94), intracranial internal carotid artery occlusion (aOR, 3.53; 95% CI, 1.50-8.32), number of passes (aOR, 1.31; 95% CI, 1.06-1.62), transient reocclusion during MT (aOR, 8.55; 95% CI, 2.14-34.09), and atherosclerotic cause (aOR, 3.14; 95% CI, 1.34-7.37) were independently associated with reocclusion. In the matched-cohort analysis, residual thrombus or stenosis was associated with reocclusion (aOR, 15.6; 95% CI, 4.6-52.8). Patients experiencing reocclusion had worse outcome (aOR, 5.0; 95% CI, 1.2-20.0). Conclusions- Reocclusion within 24-hours of successful MT was independently associated with statin pretreatment, occlusion site, more complex procedures, atherosclerotic cause, and residual thrombus or stenosis after recanalization. Reocclusion impact on long-term outcome highlights the need to monitor and prevent this early complication.

Entities:  

Keywords:  angiography; cerebral infarction; prognosis; thrombectomy; thrombosis

Mesh:

Year:  2019        PMID: 31535931     DOI: 10.1161/STROKEAHA.119.026228

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Association of Multiple Passes during Mechanical Thrombectomy with Incomplete Reperfusion and Lesion Growth.

Authors:  Marie Luby; José G Merino; Rachel Davis; Saeed Ansari; Marc Fisher; Amie W Hsia; Yongwoo Kim; Lawrence L Latour; Evan S McCreedy; Rena Sukhdeo Singh; Clinton B Wright; John K Lynch
Journal:  Cerebrovasc Dis       Date:  2021-12-13       Impact factor: 3.104

2.  Endovascular treatment of acute ischemic stroke in patients with recurrent intracranial large vessel occlusion.

Authors:  Andrej Klepanec; Jan Harsany; Jozef Haring; Miroslav Mako; Matus Hoferica; Matej Rusina; Juraj Cisar; Georgi Krastev
Journal:  Interv Neuroradiol       Date:  2020-03-17       Impact factor: 1.610

3.  Perfusion image guided mechanical thrombectomy combined with tirofiban successfully revascularize systemic lupus erythematosus related acute large vessel occlusion: A case report.

Authors:  Han Wang; Haitao Hu; Jing Xu; Cong Qian
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

4.  Infarct Growth despite Successful Endovascular Reperfusion in Acute Ischemic Stroke: A Meta-analysis.

Authors:  F Bala; J Ospel; B Mulpur; B J Kim; J Yoo; B K Menon; M Goyal; C Federau; S-I Sohn; M S Hussain; M A Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-03       Impact factor: 4.966

5.  The predictors and prognosis for unexpected reocclusion after mechanical thrombectomy: a meta-analysis.

Authors:  Xiangyu Li; Furong Gu; Jiayue Ding; Ji Bian; Na Wang; Rui Shu; Qingyun Li; Xiaolin Xu
Journal:  Ann Transl Med       Date:  2020-12

6.  Sequential tirofiban infusions combined with endovascular treatment may improve outcomes in acute ischemic stroke - a meta-analysis.

Authors:  Hongchen Zhao; Yiwei Feng; Xiaoming Rong; Yiting Mao; Zigao Wang; Yifeng Ling; Qiang Dong; Wenjie Cao
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

7.  Safety and outcome of mechanical thrombectomy in ischaemic stroke related to carotid artery dissection.

Authors:  A Karam; N Bricout; M Khyeng; C Cordonnier; X Leclerc; H Henon; B Casolla
Journal:  J Neurol       Date:  2021-06-29       Impact factor: 6.682

8.  Prognosis and risk factors for reocclusion after mechanical thrombectomy.

Authors:  Weili Li; Jiayue Ding; Xueqin Sui; Zhifeng Qi; Longfei Wu; Chenghe Sun; Kangxiang Ji; Qingfeng Ma; Xunming Ji; Ke Jian Liu
Journal:  Ann Clin Transl Neurol       Date:  2020-03-10       Impact factor: 4.511

9.  The Safety and Efficiency of Tirofiban in Acute Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Multicenter Retrospective Cohort Study.

Authors:  Lili Zhao; Yating Jian; Tao Li; Heying Wang; Zhang Lei; Man Sun; Ye Li; Yiheng Zhang; Meijuan Dang; Wang Huqing; Sun Hong; Zhang Ru; Hongxing Zhang; Yi Jia; Luo Guogang; Zhang Guilian
Journal:  Biochem Res Int       Date:  2020-04-27

10.  Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke.

Authors:  Nobuyuki Sakai; Masataka Takeuchi; Hirotoshi Imamura; Norihito Shimamura; Shinichi Yoshimura; Hiromichi Naito; Naoto Kimura; Osamu Masuo; Nobuyuki Hirotsune; Kenichi Morita; Kazunori Toyoda; Hiroshi Yamagami; Hideyuki Ishihara; Takafumi Nakatsu; Naoki Miyoshi; Miharu Suda; Shigeru Fujimoto
Journal:  Clin Drug Investig       Date:  2022-01-21       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.